#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Follicular lymphoma stage III Prolymphocytic leukaemia Oropharyngeal cancer recurrent Malignant neoplasm of choroid X-linked lymphoproliferative syndrome Fibrous dysplasia of bone Arterial disorder Anti-myelin-associated glycoprotein antibodies positive NTRK gene fusion overexpression Nodal marginal zone B-cell lymphoma Cardiac sarcoidosis Short-bowel syndrome Gastrointestinal stromal tumour Alveolar proteinosis Homocystinuria More trials…

    Learn about Rare Diseases

    Encephalitis autoimmune Hereditary hypophosphataemic rickets – Treatment Retinitis pigmentosa Adrenogenital syndrome Familial amyotrophic lateral sclerosis – Treatment Myelodysplastic syndrome with excess blasts Alveolar rhabdomyosarcoma – Diagnostics Ewing’s sarcoma – Treatment X-linked lymphoproliferative syndrome Alport’s syndrome – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Avapritinib AVTX-009 Cl-Ad-Msc-002 Dazukibart Lenacapavir Ly3556050 Tecaginlimab WEF-001 Water For Injections Heparin Calcium Vemurafenib Mycophenolate Mofetil Water For Injection Secale Cereale Xxb750 Minocycline Gemcitabine Bosutinib Abc-16F-116 NALOXEGOL More therapies…

    Learn about Your Condition

    Congenital ureteric anomaly Vascular graft thrombosis Netherton's syndrome Neonatal asphyxia Enteritis Obsessive-compulsive disorder Erectile dysfunction Acquired ATTR amyloidosis Spondylolisthesis Anogenital dysplasia Medulloblastoma Liver transplant Carotid artery occlusion Malignant glioma Drug dependence More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • A study to test the safety and effectiveness of BAY 3713372 alone and with drug combination in patients with MTAP-deleted solid tumors

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Neoplasm malignant
    Belgium Czechia Denmark Italy The Netherlands Spain +1

  • A Study Testing AOC 1020 to Improve Movement in Adults with Facioscapulohumeral Muscular Dystrophy

    Recruiting

    3 1
    Investigated Diseases:
    • Facioscapulohumeral muscular dystrophy
    Investigated Drugs:
    • Humanised Igg1 Monoclonal Antibody Against Tfr1 Conjugated To Double Stranded Sirna Oligonucleotide Against Dux4 Mrna Via A Non-Cleavable Linker
    Denmark France Germany Italy The Netherlands Spain

  • A Study Testing Anti-CD19 CAR T-Cell Therapy in Patients with Systemic Sclerosis Who Did Not Respond to Immunosuppressive Drugs

    Recruiting

    2 1 1
    Investigated Diseases:
    • Systemic scleroderma
    Investigated Drugs:
    • Autologous T-Cells Transduced With Lentiviral Vector Expressing A Chimeric Antigen Receptor Directed Against Cd19
    France

  • A Study of Repinatrabit Compared to Placebo for Treatment of Patients with Phenylketonuria

    Recruiting

    3 1
    Czechia France Germany Italy The Netherlands Poland +1

  • A Study to Test How Safe Budoprutug Is and How Well It Works in Patients with Immune Thrombocytopenia

    Recruiting

    1 1 1
    Investigated Drugs:
    • BUDOPRUTUG
    Bulgaria Greece Spain

  • Study of herbal medicine combination and bromazepam for anxiety and pain in patients having eye surgery with retrobulbar anesthesia

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Cataract
    Investigated Drugs:
    • LUPULI FLOS DRY ALCOHOLIC EXTRACT
    • TROCKENEXTRAKT AUS PASSIONSBLUMENKRAUT 5-7:1, AUSZUGSMITTEL ETHANOL 60 % (V/V)
    • VALERIAN ROOT TE WITH ETHANOL/ETHANOL WATER
    Austria
Previous Page
1 … 106 107 108 109 110 … 1,646
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!